![](https://endpts.com/wp-content/uploads/2021/11/Brian-Thomas-Metagenomi-CEO-scaled.jpg)
Brian Thomas, Metagenomi CEO
Gene editing startup Metagenomi finally sets IPO range, as preclinical biotech eyes $87M
Gene editing company Metagenomi has set a price range for its proposed initial public offering, marking a key step for preclinical biotechs after weeks of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.